Sanofi, Regeneron to Expand Alliance in Up to $8 Billion Deal — Update

By Adria CalatayudFrance's Sanofi and Regeneron Pharmaceuticals said they would expand their longstanding alliance to jointly develop and market new immunology medicines, in a deal that could net the U.S. drugmaker up to $8 billion.The two companies have collaborated for more than two decades in a…